Geisinger Healthcare System Teams with Regeneron to Sequence Patient Genomes
Geisinger Health System announced at the HLTH conference in Las Vegas that it plans to expand its population health genomics program from research into clinical practice. It will do so by sequencing patient’s DNA as part of standard care.“We’re going to start doing it the same way we would talk to patients about getting a cholesterol check,” the health system’s president and chief executive officer, David Feinberg, told reporters at the conference.